Pfizer Inc.
Market Cap
$151.74B
P/E Ratio
19.62
EPS
$1.36
Dividend Yield
6.36%
52-Week Range
$20.92 — $27.94
Volume
15.74M
Avg Volume
45.81M
Beta
0.41
P/E (TTM)
19.62
Forward P/E
9.02
PEG Ratio
-0.93
P/S (TTM)
2.46
P/B (TTM)
1.78
P/FCF
0.00
EV/EBITDA
-152.15x
EV/Sales
—
ROE (TTM)
0.09%
ROA (TTM)
0.04%
ROIC
0.00%
Gross Margin
0.70%
Operating Margin
0.25%
Net Margin
-0.09%
Debt/Equity
0.78
Current Ratio
1.16
EPS Growth (YoY)
-5.08%
Revenue Growth (YoY)
-0.01%
EPS Growth (3Y)
+0.60%
EPS Growth (5Y)
+0.72%
Sales Growth (3Y)
-0.12%
Sales Growth (5Y)
+0.17%
EPS Est (This Year)
$2.96
EPS Est (Next Year)
$2.83
Dividend Yield
—
Annual Dividend
$0.43
Payout Ratio
-1.48%
Frequency
—
Ex-Dividend Date
2025-11-07
Cash/Share
$2.39
Hold
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $27.60(3.4% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
5.69B
Float
5.68B
Free Float %
99.86%
RSI (14)
64.99
SMA 20
$26.19
SMA 50
$25.70
SMA 200
$25.02
ATR (14)
0.71
Volatility (Week)
0.03%
Volatility (Month)
0.02%
Pattern
—
1 Day
+2.07%
1 Week
+7.14%
1 Month
+8.36%
3 Months
+13.02%
6 Months
+12.33%
1 Year
—
YTD
+9.65%
All-Time High
$27.73
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
US
Exchange
NYSE
IPO Date
1972-06-01
Employees
81000
CEO
Albert Bourla
Index Membership
S&P 500
Website
https://www.pfizer.com
Pfizer Inc. (PFE) is a healthcare company in the drug manufacturers - general industry listed on the NYSE. With a market capitalization of $151.74B, a P/E ratio of 19.62, and a dividend yield of 6.36%, PFE is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PFE against other stocks using dozens of fundamental and technical filters.
Pfizer Inc. (PFE) has a trailing twelve-month (TTM) P/E ratio of 19.62. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Pfizer Inc. (PFE) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Pfizer Inc. (PFE) has a market capitalization of $151.74 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Hold" rating on Pfizer Inc. (PFE) with an average score of 3.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $27.60 implies 3.4% upside from the current price.
Pfizer Inc. (PFE) has returned +9.65% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.